I-renal cell carcinoma id 10

I-Renal cell carcinoma (RCC), uhlobo oluvame kakhulu lomdlavuza wezinso, luhlukaniswa kusetshenziswa i-International Classification of Diseases, Tenth Revision (ICD-10) ngezinjongo zokuxilonga nezibalo. Ukuqonda okuqondile I-ICD-10 amakhodi ahambisana nawo I-renal cell carcinoma kubalulekile ekugcineni amarekhodi, ukukhokha kanye nocwaningo olunembile. Lesi sihloko sinikeza ukubuka kabanzi okufanelekile I-ICD-10 amakhodi, isiteji, ukuxilongwa, kanye nezinketho zokwelashwa I-renal cell carcinoma.Ukuqonda Amakhodi e-ICD-10 e-Renal Cell CarcinomaUkuhlelwa Kwezifo Kwamazwe Ngamazwe, Ukubuyekezwa Kweshumi (I-ICD-10) kuwuhlelo olwamukelwa umhlaba wonke lokuhlukanisa izifo nezimo zezempilo. Ngoba I-renal cell carcinoma, amakhodi athile asetshenziselwa ukukhomba uhlobo, indawo, kanye nesigaba somdlavuza. Ukubhala amakhodi okunembile kubalulekile ekuqoqweni kwedatha okunembile, ukubika, kanye nembuyiselo. Amakhodi angezansi angasetshenziswa ngodokotela ezikhungweni ezifana ne I-Shandong Baofa Cancer Research Institute.Amakhodi Okulimaza AyinhlokoOkuqala I-ICD-10 Ikhodi yama-neoplasms ayingozi ezinso yi-C64. Le khodi ihlanganisa izigaba ezimbalwa ezibuye zicacise indawo kanye nezinhlangothi (izinso zesokunxele noma kwesokudla): C64.1 - I-neoplasm eyingozi yezinso zangakwesokudla, ngaphandle kwe-pelvis yezinso C64.2 - I-neoplasm eyingozi yezinso zesokunxele, ngaphandle kwe-pelvis yezinso C64.9 - I-neoplasm eyingozi yezinso engashiwongo, ngaphandle kwe-renal pelvisSecondary Malignancy Codes I-renal cell carcinoma ine-metastasized (sabalala) kwezinye izingxenye zomzimba, amakhodi esibili obubi asetshenziswa ngaphezu kwekhodi eyinhloko. Izibonelo zifaka: C79.0 - I-neoplasm yesibili eyingozi yezinso kanye ne-pelvis ye-renal (Lokhu ngeke kusetshenziswe njengekhodi eyinhloko I-renal cell carcinoma.) C79.51 - I-neoplasm yesibili eyingozi yethambo C78.0 - I-neoplasm yesibili eyingozi yamaphaphu C77.3 - I-neoplasm yesibili eyingozi ye-axilla kanye ne-lymph node yomlenze ophezulu Ukuxilongwa kanye Nesiteji Se-Renal Cell Carcinoma Ukuxilongwa okufanele kanye nesiteji kubalulekile ekunqumeni uhlelo olufanele lokwelapha I-renal cell carcinoma. Izindlela ezilandelayo zivame ukusetshenziswa: Izinqubo zokuxilonga Ukuhlolwa Kwezithombe: Ama-CT scan, ama-MRIs, nama-ultrasound asetshenziselwa ukubona ngeso lengqondo izinso nokuhlonza izimila ezingase zibe khona. I-Biopsy: Isampula yethishu ithathwa esixukwini sezinso futhi ihlolwe ngaphansi kwesibonakhulu ukuze kuqinisekiswe ukuba khona kwamangqamuzana omdlavuza. Ukuhlolwa komchamo: Ingase ithole igazi noma okunye okungavamile okuphakamisa izinkinga zezinso. Ukuhlolwa kwegazi: Hlola ukusebenza kwezinso kanye nempilo iyonke.I-TNM Staging SystemUhlelo lwesiteji lwe-TNM lusetshenziswa kabanzi ukuhlukanisa izinga I-renal cell carcinoma: T (Isimila): Ichaza ubukhulu kanye nobukhulu besimila esiyinhloko. N (Amanodi): Ibonisa ukuthi umdlavuza ususabalele yini kuma-lymph nodes aseduze. I-M (i-Metastasis): Inquma ukuthi ingabe umdlavuza usunemetastasized ezindaweni ezikude.Izigaba ze-TNM zisukela eSigabeni I (isimila sendawo) kuye kuSigaba IV (isifo se-metastatic). Isiteji siyisici esibalulekile ekunqumeni ukubikezela kanye nezinketho zokwelapha.Izinketho Zokwelashwa Kwe-Renal Cell CarcinomaUkwelashwa I-renal cell carcinoma kuncike ezicini eziningana, okuhlanganisa isigaba somdlavuza, impilo yesiguli iyonke, nezinto ezithandwa umuntu siqu. Izindlela zokwelashwa ezijwayelekile zihlanganisa:UkuhlinzwaUkususwa kwesimila ngokuhlinzwa kuvame ukuba ukwelapha okuyinhloko kokwenziwa kwendawo I-renal cell carcinoma. Izinketho zokuhlinzwa zihlanganisa: I-Nephrectomy Eyingxenye: Ukususwa kwesimila kanye nengxenye encane yezicubu ezinempilo. I-Radical Nephrectomy: Ukususwa kwazo zonke izinso, izicubu ezizungezile, nama-lymph nodes.Imithi yokwelapha ehlosiwe ivimba ama-molecule athile abandakanyeka ekukhuleni kwamangqamuzana omdlavuza kanye nokuphila. Le mithi ingasebenza kahle kwabathuthukile I-renal cell carcinoma futhi zivame ukusetshenziswa lapho ukuhlinzwa kungeyona inketho noma ngemva kokuhlinzwa ukuze kuvinjelwe ukuphindeka. Izibonelo zifaka: I-Sunitinib (Sutent) Pazopanib (Votrient) Axitinib (Inlyta) Cabozantinib (Cabometyx)ImmunotherapyIzidakamizwa ze-Immunotherapy zithuthukisa amasosha omzimba ukuze alwe namaseli omdlavuza. Le mithi ibonise imiphumela ethembisayo ekwelapheni okuthuthukile I-renal cell carcinoma. Izibonelo zifaka phakathi: I-Nivolumab (Opdivo) Pembrolizumab (Keytruda) Ipilimumab (Yervoy)I-Radiation TherapyUkwelapha ngeRadiation kusebenzisa imisebe yamandla aphezulu ukubulala amaseli omdlavuza. Kwesinye isikhathi isetshenziselwa ukwelapha I-renal cell carcinoma esesabalale kwezinye izingxenye zomzimba noma ekudambiseni izimpawu ezinjengobuhlungu.Ukuqapha OkusebenzayoAmathumba amancane akhula kancane, ukugadwa okusebenzayo (ukuqapha eduze) kungase kube inketho. Lokhu kuhilela ukuhlolwa kwesithombe okuvamile ukuze kuqashwe ukukhula kwesimila, ngokwelashwa okuqalwa uma isimila siqala ukukhula noma sibangele izimpawu.Amazinga Okubikezela kanye Nokusinda I-renal cell carcinoma kuyahlukahluka kuye ngokuthi umdlavuza ungakanani kanye nezinye izici. Isigaba sokuqala I-renal cell carcinoma inezinga eliphezulu lokusinda ngemva kokususwa ngokuhlinzwa. Nokho, ethuthukisiwe I-renal cell carcinoma kuyinselele kakhulu ukuyelapha, futhi izinga lokusinda liphansi. Intuthuko ekwelashweni okuhlosiwe kanye ne-immunotherapy iye yathuthukisa ukubikezela kweziguli ezinezifo ezithuthukile.Ithebula elilandelayo libonisa amazinga okusinda kweminyaka emi-5 ezigabeni ezahlukene I-renal cell carcinoma ngokusekelwe kudatha evela ku-American Cancer Society: Isigaba Seminyaka emihlanu Yokusinda Isigaba I 93% Isigaba II 81% Isigaba III 74% Isigaba IV 13% *Amazinga okusinda ayahlawumbisela futhi angahluka kuye ngezimo ngazinye.IsiphethoUkuqonda I-ICD-10 uhlelo lwekhodi lwe I-renal cell carcinoma, kanye nokuxilongwa kwayo, isiteji, nezinketho zokwelashwa, kubalulekile kochwepheshe bezempilo neziguli. Ukutholwa kusenesikhathi kanye nokwelashwa okufanele kungathuthukisa kakhulu imiphumela. Ukuze uthole ulwazi olwengeziwe ngocwaningo lomdlavuza kanye nokwelashwa, sicela uvakashele Shandong Baofa Cancer Research Institute mayelana nathi ikhasi.Umshwana wokuzihlangula: Lolu lwazi ngelezinjongo zokufundisa kuphela futhi akufanele luthathwe njengeseluleko sezokwelapha. Xhumana nochwepheshe bezokunakekelwa kwempilo oqeqeshiwe nganoma yikuphi ukukhathazeka ngezempilo noma ngaphambi kokwenza noma yiziphi izinqumo ezihlobene nempilo noma ukwelashwa kwakho.Imithombo: I-American Cancer Society: https://www.cancer.org/ I-National Cancer Institute: https://www.cancer.gov/